TrilliumBiO is a life sciences company specializing in the development and commercialization of novel diagnostic tests in collaboration with healthcare innovators. With a proven track record of translating clinical insights into market-ready solutions, TrilliumBiO delivers validated, physician-guided diagnostics that address complex medical challenges. Backed by strong research partnerships and a commitment to evidence-based development, TrilliumBiO transforms discovery into actionable innovations that inform real-world clinical decisions. By working together, we believe we can enable better health outcomes for all.